BG100017A - 4-арилизоиндолови аналгетици - Google Patents

4-арилизоиндолови аналгетици Download PDF

Info

Publication number
BG100017A
BG100017A BG100017A BG10001795A BG100017A BG 100017 A BG100017 A BG 100017A BG 100017 A BG100017 A BG 100017A BG 10001795 A BG10001795 A BG 10001795A BG 100017 A BG100017 A BG 100017A
Authority
BG
Bulgaria
Prior art keywords
compound
vacuo
mixture
mol
methyl
Prior art date
Application number
BG100017A
Other languages
Bulgarian (bg)
English (en)
Inventor
Richard Carmosin
John Carson
Dennis Liotta
Philip Pitis
Robert Raffa
Original Assignee
Ortho Pharmaceutical Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corporation filed Critical Ortho Pharmaceutical Corporation
Publication of BG100017A publication Critical patent/BG100017A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG100017A 1993-03-26 1995-09-20 4-арилизоиндолови аналгетици BG100017A (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3857193A 1993-03-26 1993-03-26
US9996593A 1993-07-29 1993-07-29
US08/173,586 US5508424A (en) 1993-03-26 1993-12-23 4-arylisoindole analgesics
PCT/US1994/003329 WO1994022823A1 (fr) 1993-03-26 1994-03-28 Analgesiques a base de 4-arylisoindole

Publications (1)

Publication Number Publication Date
BG100017A true BG100017A (bg) 1996-04-30

Family

ID=27365417

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100017A BG100017A (bg) 1993-03-26 1995-09-20 4-арилизоиндолови аналгетици

Country Status (19)

Country Link
US (1) US5508424A (fr)
EP (1) EP0690842B1 (fr)
JP (1) JP3326180B2 (fr)
CN (1) CN1123546A (fr)
AT (1) ATE174588T1 (fr)
AU (1) AU674746B2 (fr)
BG (1) BG100017A (fr)
CA (1) CA2159071C (fr)
CZ (1) CZ248195A3 (fr)
DE (1) DE69415307T2 (fr)
DK (1) DK0690842T3 (fr)
ES (1) ES2126750T3 (fr)
FI (1) FI954537A7 (fr)
GR (1) GR3029534T3 (fr)
HU (1) HUT74087A (fr)
NO (1) NO953785D0 (fr)
PL (1) PL310829A1 (fr)
SK (1) SK118295A3 (fr)
WO (1) WO1994022823A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543530A (en) * 1993-12-23 1996-08-06 Ortho Pharmaceutical Corporation 4-arylisoindole analgesics
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US5602167A (en) * 1995-05-17 1997-02-11 Ortho Pharmaceutical Corporation 4-arylcyclohepta[c] pyrrole analgesics
JP2004501270A (ja) * 2000-06-22 2004-01-15 ザ　ルブリゾル　コーポレイション 潤滑油および燃料のためのアシル化剤および分散剤
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
JP4629576B2 (ja) * 2002-08-14 2011-02-09 アボット・ラボラトリーズ 中枢神経系活性剤であるアザビシクロ化合物
CN102633730A (zh) 2004-12-03 2012-08-15 先灵公司 作为cb1拮抗剂的取代哌嗪
JP2009528266A (ja) * 2006-01-18 2009-08-06 シェーリング コーポレイション カンナビノイド受容体修飾因子
WO2008130616A2 (fr) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines comme modulateurs des récepteurs cb1
CA2692268A1 (fr) * 2007-06-28 2009-01-08 Intervet International B.V. Piperazines a substitution servant d'antagonistes des recepteurs cb1
CA2694264A1 (fr) * 2007-06-28 2009-01-08 Intervet International B.V. Piperazines a substitution servant d'antagonistes des recepteurs cb1
CN104513172B (zh) * 2013-09-30 2018-02-02 天士力医药集团股份有限公司 含有三氟甲基的酰胺生物碱、制备方法及其药物用途
WO2018011681A1 (fr) 2016-07-14 2018-01-18 Pfizer Inc. Nouveaux pyrimidine carboxamides utilisées comme inhibiteurs de l'enzyme vanin-1
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4042707A (en) * 1976-02-19 1977-08-16 E. I. Du Pont De Nemours And Company 3α-Arylhydroisoindoles
US4689329A (en) * 1986-02-04 1987-08-25 Mcneilab, Inc. 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
FR2676443B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives de perhydroisoindole et leur preparation.
FR2676442B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate

Also Published As

Publication number Publication date
SK118295A3 (en) 1996-06-05
NO953785L (no) 1995-09-25
JP3326180B2 (ja) 2002-09-17
DE69415307T2 (de) 1999-06-17
AU6493394A (en) 1994-10-24
WO1994022823A1 (fr) 1994-10-13
HUT74087A (en) 1996-11-28
PL310829A1 (en) 1996-01-08
CA2159071C (fr) 2005-06-28
DK0690842T3 (da) 1999-08-23
GR3029534T3 (en) 1999-06-30
FI954537A0 (fi) 1995-09-25
JPH08509212A (ja) 1996-10-01
DE69415307D1 (de) 1999-01-28
ES2126750T3 (es) 1999-04-01
FI954537L (fi) 1995-10-27
ATE174588T1 (de) 1999-01-15
US5508424A (en) 1996-04-16
EP0690842B1 (fr) 1998-12-16
CN1123546A (zh) 1996-05-29
CA2159071A1 (fr) 1994-10-13
HU9502793D0 (en) 1995-11-28
FI954537A7 (fi) 1995-10-27
AU674746B2 (en) 1997-01-09
NO953785D0 (no) 1995-09-25
EP0690842A1 (fr) 1996-01-10
CZ248195A3 (en) 1996-02-14

Similar Documents

Publication Publication Date Title
EP1192165B1 (fr) Gamma-carbolines fusionnees a heterocycles substitues
BG100017A (bg) 4-арилизоиндолови аналгетици
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
JPH09501429A (ja) 選択的ドーパミンｄ３リガンドとしての２−アミノインダン類
CA2068527A1 (fr) Antagonistes des recepteurs de la muscarine
KR20210104833A (ko) 치환된 헤테로사이클 융합 감마-카르볼린 합성
US5409929A (en) Hydroisoindolines and hydroisoquinolines as psychotropic drugs
EP0777650A1 (fr) Derives biphenylamide en tant qu'antagonistes du 5ht 1d?
US5948807A (en) Spiroindanamines and Spiroindanimides
AU700505B2 (en) 4-arylisoindole analgesics
US5541217A (en) 4-arylcyclopenta[c]pyrrole analgesics
JPH02275851A (ja) 炭化水素置換ピロリジノン類
KR20250170693A (ko) Il-17a의 소분자 조절제, 이의 제조 방법 및 사용 방법
TW200418838A (en) Compounds for the treatment of premature ejaculation
US5523412A (en) Intermediates for 4-arylcyclohepta[c]pyrrole analgesics
JP2008523045A (ja) ニューロンニコチン性アセチルコリン特異的受容体部位に結合し、コリン作動性機能の調節および習慣性障害の治療に有用である１，２，３，３ａ，８，８ａ−ヘキサヒドロ−２，７ａ−ジアダ−シクロペンタ［ａ］インデン−７−オン誘導体
JPS61161279A (ja) １，３‐ジ置換テトラヒドロピリジン類
JPS62190156A (ja) ベンゼン融合β−ジケトシクロアルキレンの対称性Ｏ−置換ジオキシム、それらの調製方法およびそれらの薬物への適用
Sup Lee et al. Asymmetric synthesis of furo-pyrrolo-isoquinoline and furo-indolizino-indole derivatives via a diastereoselective N-acyliminium ion cyclization
JPS62270581A (ja) ３−ジフエニル置換オクタヒドロインドリジン鎮痛性化合物
JP2822274B2 (ja) Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類
PL198153B1 (pl) Sposób wytwarzania pochodnych 2-fenylo-3-aminopirydyny
홍석창 A novel synthetic method for chiral α, α-dialkylmalonate via phase-transfer catalytic alkylation and its application to total synthesis of (–)-horsfiline
CA2238162A1 (fr) Composes spiro tricycliques en tant qu'antagonistes recepteurs 5ht1d
Banini Palladium-catalyzed syntheses of indoles, pyrroloindoles, quinolines; a base-mediated formation of N-alkoxyindoles, and progress toward the first total synthesis of Echinosulfone A